Journal Article
. 2010 Jan;28(10).
doi: 10.1200/JCO.2009.23.7610.

Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20

Eleftherios P Mamounas 1 Gong Tang  Bernard Fisher  Soonmyung Paik  Steven Shak  Joseph P Costantino  Drew Watson  Charles E Geyer  D Lawrence Wickerham  Norman Wolmark  
Affiliations
  • PMID: 20065188
  •     17 References
  •     143 citations

Abstract

Purpose: The 21-gene OncotypeDX recurrence score (RS) assay quantifies the risk of distant recurrence in tamoxifen-treated patients with node-negative, estrogen receptor (ER)-positive breast cancer. We investigated the association between RS and risk for locoregional recurrence (LRR) in patients with node-negative, ER-positive breast cancer from two National Surgical Adjuvant Breast and Bowel Project (NSABP) trials (NSABP B-14 and B-20).

Patients And Methods: RS was available for 895 tamoxifen-treated patients (from both trials), 355 placebo-treated patients (from B-14), and 424 chemotherapy plus tamoxifen-treated patients (from B-20). The primary end point was time to first LRR. Distant metastases, second primary cancers, and deaths before LRR were censored.

Results: In tamoxifen-treated patients, LRR was significantly associated with RS risk groups (P < .001). The 10-year Kaplan-Meier estimate of LRR was 4.% (95% CI, 2.3% to 6.3%) for patients with a low RS (< 18), 7.2% (95% CI, 3.4% to 11.0%) for those with intermediate RS (18-30), and 15.8% (95% CI, 10.4% to 21.2%) for those with a high RS (> 30). There were also significant associations between RS and LRR in placebo-treated patients from B-14 (P = .022) and in chemotherapy plus tamoxifen-treated patients from B-20 (P = .028). In multivariate analysis, RS was an independent significant predictor of LRR along with age and type of initial treatment.

Conclusion: Similar to the association between RS and risk for distant recurrence, a significant association exists between RS and risk for LRR. This information has biologic consequences and potential clinical implications relative to locoregional therapy decisions for patients with node-negative and ER-positive breast cancer.

A gene-expression signature as a predictor of survival in breast cancer.
Marc J van de Vijver, Yudong D He, +18 authors, René Bernards.
N Engl J Med, 2002 Dec 20; 347(25). PMID: 12490681
Highly Cited.
Gene expression profiling predicts clinical outcome of breast cancer.
Laura J van 't Veer, Hongyue Dai, +13 authors, Stephen H Friend.
Nature, 2002 Feb 02; 415(6871). PMID: 11823860
Highly Cited.
Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials.
Bernard Fisher, Jong-Hyeon Jeong, +5 authors, National Surgical Adjuvant Breast and Bowel Project randomised clinical trials.
Lancet, 2004 Sep 08; 364(9437). PMID: 15351193
Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials.
Alphonse Taghian, Jong-Hyeon Jeong, +4 authors, Norman Wolmark.
J Clin Oncol, 2004 Sep 29; 22(21). PMID: 15452182
A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors.
B Fisher, J Costantino, +7 authors, E R Fisher.
N Engl J Med, 1989 Feb 23; 320(8). PMID: 2644532
Highly Cited.
Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer.
B Fisher, J Dignam, +10 authors, R G Margolese.
J Natl Cancer Inst, 1997 Dec 09; 89(22). PMID: 9390536
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
Soonmyung Paik, Steven Shak, +12 authors, Norman Wolmark.
N Engl J Med, 2004 Dec 14; 351(27). PMID: 15591335
Highly Cited.
Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer.
John A Foekens, David Atkins, +17 authors, Yixin Wang.
J Clin Oncol, 2006 Mar 01; 24(11). PMID: 16505412
Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials.
Irene L Wapnir, Stewart J Anderson, +5 authors, Norman Wolmark.
J Clin Oncol, 2006 May 02; 24(13). PMID: 16648502
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
Soonmyung Paik, Gong Tang, +11 authors, Norman Wolmark.
J Clin Oncol, 2006 May 25; 24(23). PMID: 16720680
Highly Cited.
A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients.
Laurel A Habel, Steven Shak, +12 authors, Charles P Quesenberry.
Breast Cancer Res, 2006 Jun 02; 8(3). PMID: 16737553    Free PMC article.
Highly Cited.
Genomic prediction of locoregional recurrence after mastectomy in breast cancer.
Skye H Cheng, Cheng-Fang Horng, +10 authors, Andrew T Huang.
J Clin Oncol, 2006 Sep 30; 24(28). PMID: 17008701
Predicting a local recurrence after breast-conserving therapy by gene expression profiling.
Dimitry S A Nuyten, Bas Kreike, +8 authors, Marc J van de Vijver.
Breast Cancer Res, 2006 Oct 31; 8(5). PMID: 17069664    Free PMC article.
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.
Lyndsay Harris, Herbert Fritsche, +7 authors, American Society of Clinical Oncology.
J Clin Oncol, 2007 Oct 24; 25(33). PMID: 17954709
Highly Cited. Review.
Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay.
Maureen Cronin, Mylan Pho, +5 authors, Joffre B Baker.
Am J Pathol, 2003 Dec 26; 164(1). PMID: 14695316    Free PMC article.
Highly Cited.
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, +14 authors, A L Børresen-Dale.
Proc Natl Acad Sci U S A, 2001 Sep 13; 98(19). PMID: 11553815    Free PMC article.
Highly Cited.
Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial.
B Fisher, J Dignam, J Bryant, N Wolmark.
J Natl Cancer Inst, 2001 May 03; 93(9). PMID: 11333290
Review of the clinical studies using the 21-gene assay.
Catherine M Kelly, Ellen Warner, +2 authors, Kathleen I Pritchard.
Oncologist, 2010 Apr 28; 15(5). PMID: 20421266    Free PMC article.
Review.
Present-day locoregional control in patients with t1 or t2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy.
Ranjna Sharma, Isabelle Bedrosian, +12 authors, Henry M Kuerer.
Ann Surg Oncol, 2010 May 06; 17(11). PMID: 20443145    Free PMC article.
Risk factors. Oncotype DX assay predicts local recurrence in breast cancer.
Rebecca Kirk.
Nat Rev Clin Oncol, 2010 Jun 10; 7(6). PMID: 20527688
Tumor gene expression profiling in women with breast cancer. Test category: prognostic.
Cecelia Bellcross, W David Dotson.
PLoS Curr, 2010 Sep 30; 2. PMID: 20877449    Free PMC article.
The impact of age on outcome in early-stage breast cancer.
Beth M Beadle, Wendy A Woodward, Thomas A Buchholz.
Semin Radiat Oncol, 2010 Dec 08; 21(1). PMID: 21134651    Free PMC article.
Review.
Metastasis-suppressor genes in clinical practice: lost in translation?
Alexander N Shoushtari, Russell Z Szmulewitz, Carrie W Rinker-Schaeffer.
Nat Rev Clin Oncol, 2011 Apr 28; 8(6). PMID: 21522123
Review.
Physician survey of the effect of the 21-gene recurrence score assay results on treatment recommendations for patients with lymph node-positive, estrogen receptor-positive breast cancer.
Ruth Oratz, Benjamin Kim, +4 authors, Michael Broder.
J Oncol Pract, 2011 Jul 07; 7(2). PMID: 21731516    Free PMC article.
The evolution of the locoregional therapy of breast cancer.
Alice Ho, Monica Morrow.
Oncologist, 2011 Oct 04; 16(10). PMID: 21964004    Free PMC article.
Review.
The effect of Oncotype DX recurrence score on treatment recommendations for patients with estrogen receptor-positive early stage breast cancer and correlation with estimation of recurrence risk by breast cancer specialists.
Jennifer E Joh, Nicole N Esposito, +10 authors, Geza Acs.
Oncologist, 2011 Oct 22; 16(11). PMID: 22016474    Free PMC article.
Molecular pathways associated with mortality in papillary thyroid cancer.
Naris Nilubol, Chotiya Sukchotrat, +2 authors, Electron Kebebew.
Surgery, 2011 Dec 06; 150(6). PMID: 22136817    Free PMC article.
Breast cancer local therapy: what is its effect on mortality?
John R Benson, Katy A T Teo.
World J Surg, 2012 Mar 07; 36(7). PMID: 22392352
Review.
Integrative Analysis of Response to Tamoxifen Treatment in ER-Positive Breast Cancer Using GWAS Information and Transcription Profiling.
Chindo Hicks, Ranjit Kumar, Antonio Pannuti, Lucio Miele.
Breast Cancer (Auckl), 2012 Mar 09; 6. PMID: 22399860    Free PMC article.
Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study.
Lawrence J Solin, Robert Gray, +10 authors, Joseph A Sparano.
Breast Cancer Res Treat, 2012 May 02; 134(2). PMID: 22547108    Free PMC article.
Quantitative in situ measurement of estrogen receptor mRNA predicts response to tamoxifen.
Jennifer M Bordeaux, Huan Cheng, +7 authors, David L Rimm.
PLoS One, 2012 May 19; 7(5). PMID: 22606272    Free PMC article.
The implications of breast cancer molecular phenotype for radiation oncology.
Shirin Sioshansi, Kathryn E Huber, David E Wazer.
Front Oncol, 2011 Jan 01; 1. PMID: 22649753    Free PMC article.
Validation of a radiosensitivity molecular signature in breast cancer.
Steven A Eschrich, William J Fulp, +9 authors, Javier F Torres-Roca.
Clin Cancer Res, 2012 Jul 27; 18(18). PMID: 22832933    Free PMC article.
Psychosocial and Quality of Life in Women Receiving the 21-Gene Recurrence Score Assay: The Impact of Decision Style in Women with Intermediate RS.
Nadiyah Sulayman, Elizabeth Spellman, +4 authors, Suzanne C O'Neill.
J Cancer Epidemiol, 2012 Aug 18; 2012. PMID: 22899924    Free PMC article.
Cost-effectiveness of a 21-gene recurrence score assay versus Canadian clinical practice in women with early-stage estrogen- or progesterone-receptor-positive, axillary lymph-node negative breast cancer.
Malek B Hannouf, Bin Xie, Muriel Brackstone, Gregory S Zaric.
BMC Cancer, 2012 Oct 04; 12. PMID: 23031196    Free PMC article.
Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat.
Ont Health Technol Assess Ser, 2010 Jan 01; 10(23). PMID: 23074401    Free PMC article.
Evaluating the efficacy of current clinical practice of adjuvant chemotherapy in postmenopausal women with early-stage, estrogen or progesterone receptor-positive, one-to-three positive axillary lymph node, breast cancer.
M B Hannouf, M Brackstone, B Xie, G S Zaric.
Curr Oncol, 2012 Nov 13; 19(5). PMID: 23144580    Free PMC article.
Risk stratification in ductal carcinoma in situ: the role of genomic testing.
Gary M Freedman.
Curr Oncol Rep, 2012 Nov 28; 15(1). PMID: 23180216
14-3-3ζ as a predictor of early time to recurrence and distant metastasis in hormone receptor-positive and -negative breast cancers.
Anna Bergamaschi, Jonna Frasor, +5 authors, Benita S Katzenellenbogen.
Breast Cancer Res Treat, 2012 Dec 29; 137(3). PMID: 23271328    Free PMC article.
Optimizing surgical margins in breast conservation.
Preya Ananthakrishnan, Fatih Levent Balci, Joseph P Crowe.
Int J Surg Oncol, 2013 Jan 11; 2012. PMID: 23304479    Free PMC article.
New insight into Ki67 expression at the invasive front in breast cancer.
Peng Gong, Yingxin Wang, +2 authors, Zhongyu Wang.
PLoS One, 2013 Feb 06; 8(1). PMID: 23382998    Free PMC article.
Long-term analysis to objectify the tumour grading by means of automated microscopic image analysis of the nucleolar organizer regions (AgNORs) in the case of breast carcinoma.
Klaus-Jürgen Winzer, Joachim Bellach, Peter Hufnagl.
Diagn Pathol, 2013 Apr 10; 8. PMID: 23566354    Free PMC article.
A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.
Lawrence J Solin, Robert Gray, +13 authors, Sunil Badve.
J Natl Cancer Inst, 2013 May 04; 105(10). PMID: 23641039    Free PMC article.
Highly Cited.
An associated classification of triple negative breast cancer: the risk of relapse and the response to chemotherapy.
Jing Zhang, Yahong Wang, +3 authors, Yun Niu.
Int J Clin Exp Pathol, 2013 Jul 05; 6(7). PMID: 23826420    Free PMC article.
Evaluating use characteristics for the oncotype dx 21-gene recurrence score and concordance with chemotherapy use in early-stage breast cancer.
Clara Chen, Rahul Dhanda, +2 authors, Debra A Patt.
J Oncol Pract, 2013 Aug 15; 9(4). PMID: 23942918    Free PMC article.
WSG ADAPT - adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investigator initiated phase II/III trial.
Daniel Hofmann, Ulrike Nitz, +4 authors, Nadia Harbeck.
Trials, 2013 Aug 21; 14. PMID: 23958221    Free PMC article.
The impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysis.
Josh J Carlson, Joshua A Roth.
Breast Cancer Res Treat, 2013 Aug 27; 141(1). PMID: 23974828    Free PMC article.
Highly Cited. Systematic Review.
Evaluating the 21-gene assay Recurrence Score® as a predictor of clinical response to 24 weeks of neoadjuvant exemestane in estrogen receptor-positive breast cancer.
Takayuki Ueno, Norikazu Masuda, +12 authors, Masakazu Toi.
Int J Clin Oncol, 2013 Oct 09; 19(4). PMID: 24101215
Cost effectiveness of a 21-gene recurrence score assay versus Canadian clinical practice in post-menopausal women with early-stage estrogen or progesterone-receptor-positive, axillary lymph-node positive breast cancer.
Malek B Hannouf, Bin Xie, Muriel Brackstone, Gregory S Zaric.
Pharmacoeconomics, 2013 Nov 30; 32(2). PMID: 24288208
Neoadjuvant Hormonal Therapy is Associated with Comparable Outcomes to Neoadjuvant Chemotherapy in Post-Menopausal Women with Estrogen Receptor-Positive Breast Cancer.
David M Marcus, Jeffrey M Switchenko, +5 authors, Mylin A Torres.
Front Oncol, 2014 Jan 11; 3. PMID: 24409418    Free PMC article.
The application of Oncotype DX in early-stage lymph-node-positive disease.
Sarika Jain, William J Gradishar.
Curr Oncol Rep, 2014 Jan 21; 16(1). PMID: 24442572
Review.
Evaluation and correlation of risk recurrence in early breast cancer assessed by Oncotype DX®, clinicopathological markers and tumor cell dissemination in the blood and bone marrow.
Bahriye Aktas, Agnes Bankfalvi, +2 authors, Sabine Kasimir-Bauer.
Mol Clin Oncol, 2014 Mar 22; 1(6). PMID: 24649291    Free PMC article.
How does genome sequencing impact surgery?
Marlies S Reimers, Charla C Engels, +2 authors, Gerrit J Liefers.
Nat Rev Clin Oncol, 2014 Jun 25; 11(10). PMID: 24958181
Review.
The role of surgeons in building a personalized medicine program.
Genevieve M Boland, Funda Meric-Bernstam.
J Surg Oncol, 2014 Jun 27; 111(1). PMID: 24964977    Free PMC article.
Review.
Postmastectomy radiotherapy for locally advanced breast cancer receiving neoadjuvant chemotherapy.
Icro Meattini, Sara Cecchini, +13 authors, Lorenzo Livi.
Biomed Res Int, 2014 Jul 22; 2014. PMID: 25045694    Free PMC article.
Pathogenesis, prevention, diagnosis and treatment of breast cancer.
Rupen Shah, Kelly Rosso, S David Nathanson.
World J Clin Oncol, 2014 Aug 13; 5(3). PMID: 25114845    Free PMC article.
Review.
Societal cost-effectiveness analysis of the 21-gene assay in estrogen-receptor-positive, lymph-node-negative early-stage breast cancer in Japan.
Hideko Yamauchi, Chizuko Nakagawa, +9 authors, Seigo Nakamura.
BMC Health Serv Res, 2014 Sep 06; 14. PMID: 25190451    Free PMC article.
Is axillary lymph node clearance required in node-positive breast cancer?
Nigel J Bundred, Nicola L P Barnes, Emiel Rutgers, Mila Donker.
Nat Rev Clin Oncol, 2014 Nov 05; 12(1). PMID: 25367714
Review.
The 21-gene recurrence score and locoregional recurrence in breast cancer patients.
Naresh K Jegadeesh, Sunjin Kim, +7 authors, Mylin A Torres.
Ann Surg Oncol, 2014 Dec 05; 22(4). PMID: 25472643    Free PMC article.
Evaluation of the stage IB designation of the American Joint Committee on Cancer staging system in breast cancer.
Elizabeth A Mittendorf, Karla V Ballman, +8 authors, Kelly K Hunt.
J Clin Oncol, 2014 Dec 10; 33(10). PMID: 25488970    Free PMC article.
Understanding the economic value of molecular diagnostic tests: case studies and lessons learned.
Adrian Towse, Diego Ossa, +2 authors, Louis Garrison.
J Pers Med, 2013 Jan 01; 3(4). PMID: 25562729    Free PMC article.
Review.
Tailoring cancer radiotherapy through genotyping, how close are we?
O Mahmoud, B G Haffty.
Br J Radiol, 2015 Feb 11; 88(1051). PMID: 25668486    Free PMC article.
The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer.
Nikhil G Thaker, Karen E Hoffman, +10 authors, Wendy A Woodward.
Springerplus, 2015 Feb 13; 4. PMID: 25674496    Free PMC article.
Differential effect of phosphorylation-defective survivin on radiation response in estrogen receptor-positive and -negative breast cancer.
Bisrat G Debeb, Daniel L Smith, +3 authors, Wendy A Woodward.
PLoS One, 2015 Mar 13; 10(3). PMID: 25763854    Free PMC article.
Breast cancer subtype intertumor heterogeneity: MRI-based features predict results of a genomic assay.
Elizabeth J Sutton, Jung Hun Oh, +5 authors, Elizabeth A Morris.
J Magn Reson Imaging, 2015 Apr 09; 42(5). PMID: 25850931    Free PMC article.
Highly Cited.
The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial.
F Fitzal, M Filipits, +9 authors, M Gnant.
Br J Cancer, 2015 Apr 14; 112(8). PMID: 25867274    Free PMC article.
Optimal management of sentinel lymph node positive biopsy patients in early breast cancer.
Geraldine M Jacobson, Jessica F Partin, Mohamad A Salkeni.
Ann Transl Med, 2015 May 28; 3(7). PMID: 26015929    Free PMC article.
Regional Nodal Irradiation in Early-Stage Breast Cancer.
Timothy J Whelan, Ivo A Olivotto, +21 authors, MA.20 Study Investigators.
N Engl J Med, 2015 Jul 23; 373(4). PMID: 26200977    Free PMC article.
Highly Cited.
Cancer biomarker discovery and validation.
Nicolas Goossens, Shigeki Nakagawa, Xiaochen Sun, Yujin Hoshida.
Transl Cancer Res, 2015 Jul 28; 4(3). PMID: 26213686    Free PMC article.
Highly Cited.
Is There a Role for Oncotype Dx Testing in Invasive Lobular Carcinoma?
Niamh Conlon, Dara S Ross, +3 authors, Lee K Tan.
Breast J, 2015 Aug 15; 21(5). PMID: 26271749    Free PMC article.
Population-based study of the effect of gene expression profiling on adjuvant chemotherapy use in breast cancer patients under the age of 65 years.
Arnold L Potosky, Suzanne C O'Neill, +8 authors, Marc D Schwartz.
Cancer, 2015 Aug 21; 121(22). PMID: 26291519    Free PMC article.
Tailoring Adjuvant Radiation Therapy by Intraoperative Imaging to Detect Residual Cancer.
Melodi J Whitley, Ralph Weissleder, David G Kirsch.
Semin Radiat Oncol, 2015 Sep 19; 25(4). PMID: 26384279    Free PMC article.
Review.
Adoption of Gene Expression Profiling for Breast Cancer in US Oncology Practice for Women Younger Than 65 Years.
Suzanne C O'Neill, Claudine Isaacs, +8 authors, Arnold L Potosky.
J Natl Compr Canc Netw, 2015 Oct 21; 13(10). PMID: 26483061    Free PMC article.
[Determination of prognosis using gene expression analyses: Consequences for the indication for radiotherapy?].
René Baumann, David Krug.
Strahlenther Onkol, 2015 Dec 10; 192(2). PMID: 26646310
Cost effectiveness of personalized treatment in women with early breast cancer: the application of OncotypeDX and Adjuvant! Online to guide adjuvant chemotherapy in Austria.
B Jahn, U Rochau, +7 authors, U Siebert.
Springerplus, 2015 Dec 23; 4. PMID: 26693110    Free PMC article.
Targeted therapies with companion diagnostics in the management of breast cancer: current perspectives.
Meagan B Myers.
Pharmgenomics Pers Med, 2016 Feb 10; 9. PMID: 26858530    Free PMC article.
Review.
Role of Combined Sentinel Lymph Node Biopsy and Axillary Node Sampling in Clinically Node-Negative Breast Cancer.
K J Edwards, M A Dordea, R French, V Kurup.
Indian J Surg, 2016 Feb 18; 77(6). PMID: 26884657    Free PMC article.
Locoregional Recurrence by Tumor Biology in Breast Cancer Patients after Preoperative Chemotherapy and Breast Conservation Treatment.
Eunjin Jwa, Kyung Hwan Shin, +8 authors, Tae Hyun Kim.
Cancer Res Treat, 2016 Oct 19; 48(4). PMID: 26910473    Free PMC article.
Locoregional treatment of early breast cancer with isolated tumor cells or micrometastases on sentinel lymph node biopsy.
Agnès Tallet, Eric Lambaudie, +4 authors, Gilles Houvenaeghel.
World J Clin Oncol, 2016 Apr 16; 7(2). PMID: 27081647    Free PMC article.
Review.
Underutilization of gene expression profiling for early-stage breast cancer in California.
Rosemary D Cress, Yingjia S Chen, +2 authors, Kenneth W Kizer.
Cancer Causes Control, 2016 Apr 22; 27(6). PMID: 27097910    Free PMC article.
Appropriate margin for lumpectomy excision of invasive breast cancer.
Andrea V Barrio, Monica Morrow.
Chin Clin Oncol, 2016 May 12; 5(3). PMID: 27164854    Free PMC article.
Review.
Trends in the Application of Postmastectomy Radiotherapy for Breast Cancer With 1 to 3 Positive Axillary Nodes and Tumors ≤5 cm in the Modern Treatment Era: A Retrospective Korean Breast Cancer Society Report.
Jee Suk Chang, Jung Eun Choi, +6 authors, Korean Breast Cancer Society.
Medicine (Baltimore), 2016 May 14; 95(19). PMID: 27175662    Free PMC article.
Intratumor Heterogeneity Affects Gene Expression Profile Test Prognostic Risk Stratification in Early Breast Cancer.
Rekha Gyanchandani, Yan Lin, +10 authors, Adrian V Lee.
Clin Cancer Res, 2016 Nov 03; 22(21). PMID: 27185370    Free PMC article.
Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update.
Abram Recht, Elizabeth A Comen, +14 authors, Stephen B Edge.
Ann Surg Oncol, 2016 Sep 21; 24(1). PMID: 27646018    Free PMC article.
Current Management of the Axilla.
Damian McCARTAN, Mary L Gemignani.
Clin Obstet Gynecol, 2016 Oct 21; 59(4). PMID: 27660930    Free PMC article.
Review.
Hormonal Modulation of Breast Cancer Gene Expression: Implications for Intrinsic Subtyping in Premenopausal Women.
Sarah M Bernhardt, Pallave Dasari, +3 authors, Wendy V Ingman.
Front Oncol, 2016 Nov 30; 6. PMID: 27896218    Free PMC article.
Review.
Cancer Risk after Fat Transfer: A Multicenter Case-Cohort Study.
Terence M Myckatyn, I Janelle Wagner, +9 authors, Clara N Lee.
Plast Reconstr Surg, 2016 Dec 28; 139(1). PMID: 28027219    Free PMC article.
Prognostic Impact of Elective Supraclavicular Nodal Irradiation for Patients with N1 Breast Cancer after Lumpectomy and Anthracycline Plus Taxane-Based Chemotherapy (KROG 1418): A Multicenter Case-Controlled Study.
Haeyoung Kim, Won Park, +19 authors, Jihye Cha.
Cancer Res Treat, 2017 Jan 06; 49(4). PMID: 28052649    Free PMC article.
Precision medicine in early breast cancer-can this apply to radiotherapy?
Samuel G W Ow, Soo-Chin Lee.
J Thorac Dis, 2017 Jan 10; 8(11). PMID: 28066563    Free PMC article.
21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy.
Eleftherios P Mamounas, Qing Liu, +14 authors, Norman Wolmark.
J Natl Cancer Inst, 2017 Jan 27; 109(4). PMID: 28122895    Free PMC article.
Trends and controversies in multidisciplinary care of the patient with breast cancer.
Laura S Dominici, Monica Morrow, +2 authors, Tari A King.
Curr Probl Surg, 2017 Feb 06; 53(12). PMID: 28160790    Free PMC article.
Review.
Outcomes in patients with early-stage breast cancer who underwent a 21-gene expression assay.
Carlos H Barcenas, Akshara Raghavendra, +10 authors, Debu Tripathy.
Cancer, 2017 Feb 16; 123(13). PMID: 28199747    Free PMC article.
Does adjuvant radiation therapy benefit women with small mammography-detected breast cancers?
K Jerzak, N Dudalski, +2 authors, S A Narod.
Curr Oncol, 2017 Mar 09; 24(1). PMID: 28270722    Free PMC article.
Normalization of compression-induced hemodynamics in patients responding to neoadjuvant chemotherapy monitored by dynamic tomographic optical breast imaging (DTOBI).
Amir Y Sajjadi, Steven J Isakoff, +9 authors, Stefan A Carp.
Biomed Opt Express, 2017 Mar 09; 8(2). PMID: 28270967    Free PMC article.
Distribution patterns of 21-gene recurrence score in 980 Chinese estrogen receptor-positive, HER2-negative early breast cancer patients.
Jiayi Wu, Yan Fang, +11 authors, Kunwei Shen.
Oncotarget, 2017 Apr 14; 8(24). PMID: 28404972    Free PMC article.
A high-throughput method to detect RNA profiling by integration of RT-MLPA with next generation sequencing technology.
Jing Wang, Xue Yang, +5 authors, Jidong Gao.
Oncotarget, 2017 May 26; 8(28). PMID: 28545022    Free PMC article.
21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer.
Gulisa Turashvili, Joanne F Chou, +5 authors, Hannah Y Wen.
Breast Cancer Res Treat, 2017 Jul 14; 166(1). PMID: 28702894    Free PMC article.
Comparison of Oncotype DX® Recurrence Score® with other risk assessment tools including the Nottingham Prognostic Index in the identification of patients with low-risk invasive breast cancer.
Maura Bríd Cotter, Alex Dakin, +5 authors, Cecily M Quinn.
Virchows Arch, 2017 Jul 15; 471(3). PMID: 28707056
Clinical utility of multigene profiling assays in early-stage breast cancer.
M C Chang, L H Souter, +6 authors, Molecular Oncology Advisory Committee.
Curr Oncol, 2017 Nov 02; 24(5). PMID: 29089811    Free PMC article.
Molecular Subtypes and Local-Regional Control of Breast Cancer.
Simona Maria Fragomeni, Andrew Sciallis, Jacqueline S Jeruss.
Surg Oncol Clin N Am, 2017 Nov 15; 27(1). PMID: 29132568    Free PMC article.
Review.
Large-scale DNA organization is a prognostic marker of breast cancer survival.
Martial Guillaud, Qian Ye, +5 authors, Mira Keyes.
Med Oncol, 2017 Dec 08; 35(1). PMID: 29214466
Enrichment of high-grade tumors in breast cancer gene expression studies.
M van Seijen, A L Mooyaart, +7 authors, E H Lips.
Breast Cancer Res Treat, 2017 Dec 20; 168(2). PMID: 29256013    Free PMC article.
Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
R Colomer, I Aranda-López, +7 authors, J Palacios-Calvo.
Clin Transl Oncol, 2017 Dec 24; 20(7). PMID: 29273958    Free PMC article.
Review.
21-gene recurrence assay in patients receiving intraoperative radiotherapy: are "favorable" characteristics a surrogate for low recurrence?
Bridget A Oppong, Surupa Sen Gupta, +6 authors, Shawna C Willey.
Gland Surg, 2018 Jan 06; 6(6). PMID: 29302485    Free PMC article.
Breast carcinoma with 21-gene recurrence score lower than 18: rate of locoregional recurrence in a large series with clinical follow-up.
Gulisa Turashvili, Edi Brogi, +4 authors, Hannah Y Wen.
BMC Cancer, 2018 Jan 07; 18(1). PMID: 29304773    Free PMC article.
Can Interrogation of Tumour Characteristics Lead us to Safely Omit Adjuvant Radiotherapy in Patients with Early Breast Cancer?
I S Bhattacharya, A M Kirby, J M Bliss, C E Coles.
Clin Oncol (R Coll Radiol), 2018 Jan 15; 30(3). PMID: 29331262    Free PMC article.
Review.
Margins in breast cancer: How much is enough?
Melissa Pilewskie, Monica Morrow.
Cancer, 2018 Jan 18; 124(7). PMID: 29338088    Free PMC article.
Review.
Investigating a multigene prognostic assay based on significant pathways for Luminal A breast cancer through gene expression profile analysis.
Haiyan Gao, Mei Yang, Xiaolan Zhang.
Oncol Lett, 2018 Mar 17; 15(4). PMID: 29545900    Free PMC article.
De-escalation of breast radiotherapy after conserving surgery in low-risk early breast cancer patients.
Pierfrancesco Franco, Giuseppe Carlo Iorio, +4 authors, Umberto Ricardi.
Med Oncol, 2018 Apr 05; 35(5). PMID: 29616366
Review.
Precision Medicine for Breast Cancer: The Paths to Truly Individualized Diagnosis and Treatment.
Eleanor E R Harris.
Int J Breast Cancer, 2018 Jun 05; 2018. PMID: 29862084    Free PMC article.
Review.
Integrating Radiosensitivity and Immune Gene Signatures for Predicting Benefit of Radiotherapy in Breast Cancer.
Yi Cui, Bailiang Li, +2 authors, Ruijiang Li.
Clin Cancer Res, 2018 Jun 21; 24(19). PMID: 29921729    Free PMC article.
Machine Learning and Radiogenomics: Lessons Learned and Future Directions.
John Kang, Tiziana Rancati, +6 authors, Barry S Rosenstein.
Front Oncol, 2018 Jul 07; 8. PMID: 29977864    Free PMC article.
Review.
Personalizing Radiation Treatment Delivery in the Management of Breast Cancer.
Kamran A Ahmed, G Daniel Grass, +7 authors, Roberto Diaz.
Int J Breast Cancer, 2018 Jul 10; 2018. PMID: 29984003    Free PMC article.
Review.
Practical Consequences Resulting from the Analysis of a 21-Multigene Array in the Interdisciplinary Conference of a Breast Cancer Center.
Hans-Ullrich Voelker, Lea Frey, Annette Strehl, Michael Weigel.
Int J Breast Cancer, 2018 Aug 17; 2018. PMID: 30112216    Free PMC article.
Levels of uPA and PAI-1 in breast cancer and its correlation to Ki67-index and results of a 21-multigene-array.
Hans-Ullrich Völker, Michael Weigel, Annette Strehl, Lea Frey.
Diagn Pathol, 2018 Sep 02; 13(1). PMID: 30170623    Free PMC article.
Molecular determinants of post-mastectomy breast cancer recurrence.
Kimberly S Keene, Tari King, +17 authors, Funda Meric-Bernstam.
NPJ Breast Cancer, 2018 Oct 23; 4. PMID: 30345349    Free PMC article.
The effects of postoperative radiotherapy on survival outcomes in patients under 65 with estrogen receptor positive tubular breast carcinoma.
Jian-Xian Chen, Wen-Wen Zhang, +3 authors, San-Gang Wu.
Radiat Oncol, 2018 Nov 22; 13(1). PMID: 30458816    Free PMC article.
Clinical decision making in postmastectomy radiotherapy in node negative breast cancer.
Rodrigo Barrientos, Suraj Samtani, +3 authors, Mauricio Burotto.
Ecancermedicalscience, 2018 Nov 30; 12. PMID: 30483354    Free PMC article.
Review.
Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial.
Guido Henke, Michael Knauer, +14 authors, Walter P Weber.
Trials, 2018 Dec 06; 19(1). PMID: 30514362    Free PMC article.
Evaluation of the Incorporation of Recurrence Score into the American Joint Committee on Cancer Eighth Edition Staging System in Patients with T1-2N0M0, Estrogen Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Invasive Breast Cancer: A Population-Based Analysis.
Shuning Ding, Jiayi Wu, +6 authors, Li Zhu.
Oncologist, 2019 Apr 26; 24(11). PMID: 31019021    Free PMC article.
Utilizing the genomically adjusted radiation dose (GARD) to personalize adjuvant radiotherapy in triple negative breast cancer management.
Kamran A Ahmed, Casey L Liveringhouse, +10 authors, Javier F Torres-Roca.
EBioMedicine, 2019 Aug 17; 47. PMID: 31416721    Free PMC article.
Decision of Adjuvant Systemic Treatment in HR+ HER2- Early Invasive Breast Cancer: Which Biomarkers Could Help?
Marie Alexandre, Aurélie Maran-Gonzalez, +6 authors, Séverine Guiu.
Cancer Manag Res, 2019 Dec 19; 11. PMID: 31849525    Free PMC article.
Review.
Clinicogenomic Radiotherapy Classifier Predicting the Need for Intensified Locoregional Treatment After Breast-Conserving Surgery for Early-Stage Breast Cancer.
Martin Sjöström, S Laura Chang, +10 authors, Per Karlsson.
J Clin Oncol, 2019 Oct 17; 37(35). PMID: 31618132    Free PMC article.
Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer.
Wendy A Woodward, William E Barlow, +15 authors, Kathy S Albain.
JAMA Oncol, 2020 Jan 10; 6(4). PMID: 31917424    Free PMC article.
Omission of postoperative radiation after breast conserving surgery: A progressive paradigm shift towards precision medicine.
Pierfrancesco Franco, Fiorenza De Rose, +5 authors, Clinical Oncology Breast Cancer Group (COBCG) Investigators.
Clin Transl Radiat Oncol, 2020 Feb 25; 21. PMID: 32090175    Free PMC article.
Review.
Indications for prognostic gene expression profiling in early breast cancer.
Erin F Cobain, Daniel F Hayes.
Curr Treat Options Oncol, 2015 May 02; 16(5). PMID: 25929335
Review.
Racial Differences in 21-Gene Recurrence Scores Among Patients With Hormone Receptor-Positive, Node-Negative Breast Cancer.
Andreana N Holowatyj, Michele L Cote, +5 authors, Kristen S Purrington.
J Clin Oncol, 2018 Jan 18; 36(7). PMID: 29341832    Free PMC article.
Simulation Modeling of Cancer Clinical Trials: Application to Omitting Radiotherapy in Low-risk Breast Cancer.
Jinani Jayasekera, Yisheng Li, +21 authors, CISNET-BOLD Collaborative Group.
J Natl Cancer Inst, 2018 May 03; 110(12). PMID: 29718314    Free PMC article.
Effects of Radiotherapy in Early-Stage, Low-Recurrence Risk, Hormone-Sensitive Breast Cancer.
Jinani Jayasekera, Clyde B Schechter, +17 authors, CISNET-BOLD Collaborative Group.
J Natl Cancer Inst, 2018 Sep 22; 110(12). PMID: 30239794    Free PMC article.
Development of Malignancy-Risk Gene Signature Assay for Predicting Breast Cancer Risk.
James Sun, Dung-Tsa Chen, +7 authors, M Catherine Lee.
J Surg Res, 2019 Aug 17; 245. PMID: 31419640    Free PMC article.
Localization of GPSM2 in the Nucleus of Invasive Breast Cancer Cells Indicates a Poor Prognosis.
Mingming Deng, Zhe Zhang, +7 authors, Qingjie Lv.
Front Oncol, 2020 Mar 21; 10. PMID: 32195179    Free PMC article.
Gene Expression Profiling Tests for Early-Stage Invasive Breast Cancer: A Health Technology Assessment.
Ontario Health (Quality).
Ont Health Technol Assess Ser, 2020 Apr 15; 20(10). PMID: 32284770    Free PMC article.
The Correlation of Magee EquationsTM and Oncotype DX® Recurrence Score From Core Needle Biopsy Tissues in Predicting Response to Neoadjuvant Chemotherapy in ER+ and HER2- Breast Cancer.
Atilla Soran, Kaori Tane, Efe Sezgin, Rohit Bhargava.
Eur J Breast Health, 2020 Apr 15; 16(2). PMID: 32285033    Free PMC article.
Racial Disparities in Breast Cancer Outcomes in the Metropolitan Atlanta Area: New Insights and Approaches for Health Equity.
Lindsay J Collin, Renjian Jiang, +10 authors, Lauren E McCullough.
JNCI Cancer Spectr, 2020 Apr 25; 3(3). PMID: 32328557    Free PMC article.
Commercially Available Gene Expression Assays as Predictive Tools for Adjuvant Radiotherapy? A Critical Review.
David Krug, René Baumann, +12 authors, Rolf Sauer.
Breast Care (Basel), 2020 May 14; 15(2). PMID: 32398980    Free PMC article.
Review.
Can a subgroup at high risk for LRR be identified from T1-2 breast cancer with negative lymph nodes after mastectomy? A meta-analysis.
Gongling Peng, Zhuohui Zhou, Ming Jiang, Fan Yang.
Biosci Rep, 2019 Sep 06; 39(9). PMID: 31484798    Free PMC article.
Impact of Oncotype DX Recurrence Score on the Patterns of Locoregional Recurrence in Breast Cancer (Korean Radiation Oncology Group 19-06).
Kyubo Kim, Jinhong Jung, +7 authors, Jee Suk Chang.
J Breast Cancer, 2020 Jul 01; 23(3). PMID: 32595993    Free PMC article.
De-Escalation of Locoregional Therapy in Low-Risk Disease for DCIS and Early-Stage Invasive Cancer.
E Shelley Hwang, Lawrence Solin.
J Clin Oncol, 2020 May 23; 38(20). PMID: 32442066    Free PMC article.
Review.
Sex Disparity Observed for Oncotype DX Breast Recurrence Score in Predicting Mortality Among Patients with Early Stage ER-Positive Breast Cancer.
Fei Wang, Sonya Reid, +6 authors, Xiao-Ou Shu.
Clin Cancer Res, 2019 Nov 22; 26(1). PMID: 31748278    Free PMC article.
Association between the 21-gene recurrence score and isolated locoregional recurrence in stage I-II, hormone receptor-positive breast cancer.
David D Yang, Daniela L Buscariollo, +11 authors, Rinaa S Punglia.
Radiat Oncol, 2020 Aug 18; 15(1). PMID: 32799886    Free PMC article.
The importance of surgical margins in breast cancer.
Colleen M O'Kelly Priddy, Victoria A Forte, Julie E Lang.
J Surg Oncol, 2015 Sep 24; 113(3). PMID: 26394558    Free PMC article.
Review.
Applying Precision Oncology Principles in Radiation Oncology.
Sophia C Kamran, Kent W Mouw.
JCO Precis Oncol, 2018 May 14; 2. PMID: 32914000    Free PMC article.
Review.
Simulation modeling for clinical trials evaluating radiotherapy omission in low-risk early breast cancer.
Pierfrancesco Franco, Umberto Ricardi.
Ann Transl Med, 2019 Jan 08; 6(Suppl 1). PMID: 30613618    Free PMC article.
The Distribution and Outcomes of the 21-Gene Recurrence Score in T1-T2N0 Estrogen Receptor-Positive Breast Cancer With Different Histologic Subtypes.
Jun Wang, Zhen-Yu He, +3 authors, San-Gang Wu.
Front Genet, 2019 Jan 09; 9. PMID: 30619463    Free PMC article.
Examination of the Biomark assay as an alternative to Oncotype DX for defining chemotherapy benefit.
Jinkyoung Kim, Aeree Kim, Chungyeul Kim.
Oncol Lett, 2019 Jan 25; 17(2). PMID: 30675242    Free PMC article.
21-Gene Recurrence Score Assay and Outcomes of Adjuvant Radiotherapy in Elderly Women With Early-Stage Breast Cancer After Breast-Conserving Surgery.
San-Gang Wu, Wen-Wen Zhang, +4 authors, Zhen-Yu He.
Front Oncol, 2019 Feb 15; 9. PMID: 30761267    Free PMC article.
Effect of 21-gene recurrence score in decision-making for surgery in early stage breast cancer.
San-Gang Wu, Wen-Wen Zhang, +3 authors, Zhen-Yu He.
Onco Targets Ther, 2019 Apr 10; 12. PMID: 30962690    Free PMC article.
21-Gene Recurrence Score Assay Could Not Predict Benefit of Post-mastectomy Radiotherapy in T1-2 N1mic ER-Positive HER2-Negative Breast Cancer.
Wen-Wen Zhang, Qin Tong, +8 authors, Huan-Xin Lin.
Front Oncol, 2019 May 02; 9. PMID: 31041190    Free PMC article.
Validation of a Risk Score Incorporating Tumor Characteristics into the American Joint Committee on Cancer Anatomic Stage for Breast Cancer.
Yi Heng Seow, Ru Xin Wong, +3 authors, Fuh Yong Wong.
J Breast Cancer, 2019 Jul 10; 22(2). PMID: 31281728    Free PMC article.
Validation of a Novel Nomogram for Prediction of Local Relapse after Surgery for Invasive Breast Carcinoma.
Giovanni Corso, Patrick Maisonneuve, +9 authors, Paolo Veronesi.
Ann Surg Oncol, 2020 Jan 23; 27(6). PMID: 31965372    Free PMC article.
Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology.
Iris Schrijver, Nazneen Aziz, +16 authors, Jane S Gibson.
J Mol Diagn, 2012 Aug 25; 14(6). PMID: 22918138    Free PMC article.
Radiomics signature on 3T dynamic contrast-enhanced magnetic resonance imaging for estrogen receptor-positive invasive breast cancers: Preliminary results for correlation with Oncotype DX recurrence scores.
Kyung Jin Nam, Hyunjin Park, +3 authors, Jeong Eon Lee.
Medicine (Baltimore), 2019 Jun 07; 98(23). PMID: 31169691    Free PMC article.
Characterization of molecular scores and gene expression signatures in primary breast cancer, local recurrences and brain metastases.
Mariana Bustamante Eduardo, Vlad Popovici, +5 authors, Rolf Jaggi.
BMC Cancer, 2019 Jun 09; 19(1). PMID: 31174485    Free PMC article.
Racial differences in estrogen receptor staining levels and implications for treatment and survival among estrogen receptor positive, HER2-negative invasive breast cancers.
Kristen S Purrington, David Gorski, +5 authors, Manohar Ratnam.
Breast Cancer Res Treat, 2020 Apr 03; 181(1). PMID: 32236827
Insights into the theranostic value of precision medicine on advanced radiotherapy to breast cancer.
Man Jiang, Jianshe Yang, +3 authors, Meiqin Tang.
Int J Med Sci, 2021 Jan 14; 18(3). PMID: 33437197    Free PMC article.
Review.
Oncotype DX testing in node-positive breast cancer strongly impacts chemotherapy use at a comprehensive cancer center.
Katya Losk, Rachel A Freedman, +7 authors, Tari A King.
Breast Cancer Res Treat, 2020 Sep 18; 185(1). PMID: 32939592
How Canadian Oncologists Use Oncotype DX for Treatment of Breast Cancer Patients.
Xiaofu Zhu, Susan Dent, +5 authors, Xinni Song.
Curr Oncol, 2021 Feb 10; 28(1). PMID: 33557029    Free PMC article.
Personalization in Modern Radiation Oncology: Methods, Results and Pitfalls. Personalized Interventions and Breast Cancer.
Cynthia Aristei, Elisabetta Perrucci, +4 authors, Gianluca Ingrosso.
Front Oncol, 2021 Apr 06; 11. PMID: 33816246    Free PMC article.
Review.
De-escalation of radiation therapy in patients with stage I, node-negative, HER2-positive breast cancer.
Jose G Bazan, Sachin R Jhawar, +4 authors, Julia R White.
NPJ Breast Cancer, 2021 Mar 27; 7(1). PMID: 33767168    Free PMC article.
Prognostic value of the 21-gene recurrence score for regional recurrence in patients with estrogen receptor-positive breast cancer.
Minji Koh, Jinhong Jung, +6 authors, Jae Ho Jeong.
Breast Cancer Res Treat, 2021 Apr 24;. PMID: 33891300